1. Home
  2. BOLD vs HOLO Comparison

BOLD vs HOLO Comparison

Compare BOLD & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • HOLO
  • Stock Information
  • Founded
  • BOLD 2018
  • HOLO 2018
  • Country
  • BOLD United States
  • HOLO China
  • Employees
  • BOLD N/A
  • HOLO N/A
  • Industry
  • BOLD
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • BOLD
  • HOLO Technology
  • Exchange
  • BOLD Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • BOLD 24.4M
  • HOLO 24.9M
  • IPO Year
  • BOLD 2024
  • HOLO N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • HOLO $4.67
  • Analyst Decision
  • BOLD Buy
  • HOLO
  • Analyst Count
  • BOLD 3
  • HOLO 0
  • Target Price
  • BOLD $4.00
  • HOLO N/A
  • AVG Volume (30 Days)
  • BOLD 105.5K
  • HOLO 4.7M
  • Earning Date
  • BOLD 08-11-2025
  • HOLO 01-01-0001
  • Dividend Yield
  • BOLD N/A
  • HOLO N/A
  • EPS Growth
  • BOLD N/A
  • HOLO N/A
  • EPS
  • BOLD N/A
  • HOLO N/A
  • Revenue
  • BOLD N/A
  • HOLO $39,771,750.00
  • Revenue This Year
  • BOLD N/A
  • HOLO N/A
  • Revenue Next Year
  • BOLD N/A
  • HOLO N/A
  • P/E Ratio
  • BOLD N/A
  • HOLO N/A
  • Revenue Growth
  • BOLD N/A
  • HOLO 42.62
  • 52 Week Low
  • BOLD $1.00
  • HOLO $4.16
  • 52 Week High
  • BOLD $4.72
  • HOLO $608.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • HOLO 39.89
  • Support Level
  • BOLD N/A
  • HOLO $5.07
  • Resistance Level
  • BOLD N/A
  • HOLO $5.27
  • Average True Range (ATR)
  • BOLD 0.00
  • HOLO 0.80
  • MACD
  • BOLD 0.00
  • HOLO -0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • HOLO 0.19

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: